DE1618813A1 - Verfahren zur Herstellung von delta?-Testosteron - Google Patents
Verfahren zur Herstellung von delta?-TestosteronInfo
- Publication number
- DE1618813A1 DE1618813A1 DE19641618813 DE1618813A DE1618813A1 DE 1618813 A1 DE1618813 A1 DE 1618813A1 DE 19641618813 DE19641618813 DE 19641618813 DE 1618813 A DE1618813 A DE 1618813A DE 1618813 A1 DE1618813 A1 DE 1618813A1
- Authority
- DE
- Germany
- Prior art keywords
- radical
- formula
- testosterone
- oxo
- bad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 8
- 229960003604 testosterone Drugs 0.000 title claims description 8
- 230000008569 process Effects 0.000 title claims description 4
- 238000004519 manufacturing process Methods 0.000 title description 7
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 21
- -1 diene diamines Chemical class 0.000 claims description 9
- 150000003335 secondary amines Chemical class 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 150000003512 tertiary amines Chemical class 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 150000002081 enamines Chemical class 0.000 description 5
- 150000003431 steroids Chemical class 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 150000001993 dienes Chemical group 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- NYGWTZLABYSHOP-FCYODTKKSA-N (8R,9S,10S,13R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12-decahydro-1H-cyclopenta[a]phenanthrene Chemical compound C([C@H]12)CC3CCCC[C@]3(C)[C@H]1CC[C@@]1(C)C2=CC=C1 NYGWTZLABYSHOP-FCYODTKKSA-N 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000003974 aralkylamines Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002983 circular dichroism Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- GUAWMXYQZKVRCW-UHFFFAOYSA-N n,2-dimethylaniline Chemical compound CNC1=CC=CC=C1C GUAWMXYQZKVRCW-UHFFFAOYSA-N 0.000 description 1
- HVAAHUDGWQAAOJ-UHFFFAOYSA-N n-benzylethanamine Chemical compound CCNCC1=CC=CC=C1 HVAAHUDGWQAAOJ-UHFFFAOYSA-N 0.000 description 1
- PXSXRABJBXYMFT-UHFFFAOYSA-N n-hexylhexan-1-amine Chemical compound CCCCCCNCCCCCC PXSXRABJBXYMFT-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 150000005671 trienes Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR951070A FR1381417A (fr) | 1963-10-18 | 1963-10-18 | Amines stéroïdes et procédé de préparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1618813A1 true DE1618813A1 (de) | 1971-02-25 |
Family
ID=8814690
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19641468886 Withdrawn DE1468886B1 (de) | 1963-10-18 | 1964-10-07 | Verfahren zur Herstellung von Steroid-3,5-dien-1,3-diaminen bzw. von Steroid-1,3,5-trien-3-aminen |
| DE19641618813 Pending DE1618813A1 (de) | 1963-10-18 | 1964-10-07 | Verfahren zur Herstellung von delta?-Testosteron |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19641468886 Withdrawn DE1468886B1 (de) | 1963-10-18 | 1964-10-07 | Verfahren zur Herstellung von Steroid-3,5-dien-1,3-diaminen bzw. von Steroid-1,3,5-trien-3-aminen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3274176A (enExample) |
| CH (1) | CH437271A (enExample) |
| DE (2) | DE1468886B1 (enExample) |
| FR (1) | FR1381417A (enExample) |
| GB (1) | GB1016730A (enExample) |
| NL (2) | NL6411832A (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005070951A1 (en) | 2004-01-16 | 2005-08-04 | Cedarburg Pharmaceuticals, Inc. | Exemestane and its intermediates and methods of making the same |
| US20080119447A1 (en) * | 2005-09-30 | 2008-05-22 | James Yarger | 6-alkoxyalkyl estradiol derivatives and methods of use |
| US8168621B2 (en) | 2005-09-30 | 2012-05-01 | Endece, Llc | 6-substituted estradiol derivatives and methods of use |
| US10174070B2 (en) | 2005-09-30 | 2019-01-08 | Endece Llc | 6-substituted estradiol derivatives and methods of use |
| US20080275259A1 (en) | 2007-05-04 | 2008-11-06 | Scinopharm Taiwan, Ltd | Process for preparing aromatase inhibitors |
| BR112013005843A2 (pt) | 2010-09-14 | 2019-12-10 | Endece Llc | derivativos de er-beta 6-substituído por desmetil-estradiol |
-
0
- NL NL122154D patent/NL122154C/xx active
-
1963
- 1963-10-18 FR FR951070A patent/FR1381417A/fr not_active Expired
-
1964
- 1964-10-07 DE DE19641468886 patent/DE1468886B1/de not_active Withdrawn
- 1964-10-07 DE DE19641618813 patent/DE1618813A1/de active Pending
- 1964-10-09 CH CH1312464A patent/CH437271A/fr unknown
- 1964-10-12 NL NL6411832A patent/NL6411832A/xx unknown
- 1964-10-14 US US403936A patent/US3274176A/en not_active Expired - Lifetime
- 1964-10-15 GB GB42126/64A patent/GB1016730A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1016730A (en) | 1966-01-12 |
| NL122154C (enExample) | |
| DE1468886B1 (de) | 1970-04-30 |
| FR1381417A (fr) | 1964-12-14 |
| CH437271A (fr) | 1967-06-15 |
| US3274176A (en) | 1966-09-20 |
| NL6411832A (enExample) | 1965-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3872995T2 (de) | Verfahren zur herstellung von androsta-1,4-dien-3,17-dion-methylen-derivaten. | |
| DE3321826A1 (de) | 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate | |
| DE1618813A1 (de) | Verfahren zur Herstellung von delta?-Testosteron | |
| DE1668784B2 (de) | Verfahren zur herstellung von aldehyden oder ketonen durch oxydation primaerer oder sekundaerer alkohole | |
| DE1152101B (de) | Verfahren zur Herstellung von mit einem Pyrazolring kondensierten Steroidverbindungen | |
| DE951363C (de) | Verfahren zur Herstellung von 4-Pregnen-11ª, 17ª-diol-3, 20-dion | |
| DE1493169A1 (de) | Verfahren zur Herstellung von 5 beta-Bisnorcholanderivaten | |
| DE1468886C (de) | Verfahren zur Herstellung von Steroid-3,5-dien-l,3-diaminen bzw. von Steroidl,3,5-trien-3~aminen | |
| DE1695667A1 (de) | Neue Pyrrolderivate,deren Herstellung und deren Verwendung | |
| DE2055895A1 (de) | Verfahren zur Herstellung von Steroiddenvaten | |
| DE1470317A1 (de) | Verfahren zur Herstellung von Benzoyl-Pyridinociminoaethern und -estern | |
| DE1568767C3 (de) | 3-Äthyliden-3 alpha, beta-methyl-perhydrobenz eckige Klammer auf e eckige Klammer zu indene und ein Verfahren zur Herstellung von 3-Äthyliden-3 alpha, beta-methyl perhydrobenz eckige Klammer auf e eckige Klammer zu indenen und 3 beta-(1 -Hydroxyäthyl) - 3 alpha betamethylbenz eckige Klammer auf e eckige Klammer zu indenen | |
| DE1618871A1 (de) | Verfahren zur Herstellung von Steroidketonen und ihrer Derivate | |
| DE2226067C3 (de) | Verfahren zur Herstellung von 16beta-Methyl-17alpha -hydroxy-1,4,9(11 )pregnatrien-3,20-dion(1) | |
| DE1220414B (de) | Verfahren zur Herstellung von in 4-Stellung ungesaettigten 6-Methylen-3-oxo-steroid-verbindungen der Androstan-, Pregnan- und Spirostanreihe | |
| DE3426771C2 (de) | 13alpha-Methylgonane, deren Herstellung und Verwendung | |
| DE1443466C (de) | Verfahren zur Herstellung von 2 En 3 olathern von 2 Formyl 3 oxo 5 alpha sterol den | |
| DE1179548B (de) | Verfahren zur Herstellung von 21-Bromsteroiden | |
| DD251142A1 (de) | Verfahren zur herstellung von 16 alpha, 17 alpha-cyclohexano-17 beta-acetylgonen-3-onen | |
| DE892449C (de) | Verfahren zur Reduktion von Ketogruppen in Ketosteroiden mit wenigstens einer ungesaettigten reduzierbaren Kohlenstoff-Stickstoff-Bindung | |
| DE3320580A1 (de) | D-homo-4,9,16-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate | |
| AT232203B (de) | Verfahren zur Herstellung von 3β-Hydroxy-6-methyl-Δ<5>-steroiden | |
| AT228410B (de) | Verfahren zur Herstellung neuer 6-Methyl-3-oxo-4, 6-dien-steroide | |
| DE946899C (de) | Verfahren zur Herstellung von 5-Pregnen-3, 17ª‡-diol-20-on | |
| DE1568767A1 (de) | Verfahren zur Herstellung von Benzindenen |